BE838833A - Composes 3-acyloxymethyl-cephemes, leur preparation et leur utilisation - Google Patents

Composes 3-acyloxymethyl-cephemes, leur preparation et leur utilisation

Info

Publication number
BE838833A
BE838833A BE164543A BE164543A BE838833A BE 838833 A BE838833 A BE 838833A BE 164543 A BE164543 A BE 164543A BE 164543 A BE164543 A BE 164543A BE 838833 A BE838833 A BE 838833A
Authority
BE
Belgium
Prior art keywords
cephemes
acyloxymethyl
compounds
preparation
cephemes compounds
Prior art date
Application number
BE164543A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2315875A external-priority patent/JPS5837316B2/ja
Priority claimed from JP3375975A external-priority patent/JPS5951553B2/ja
Priority claimed from JP3471475A external-priority patent/JPS5951554B2/ja
Priority claimed from JP127476A external-priority patent/JPS5283869A/ja
Application filed filed Critical
Publication of BE838833A publication Critical patent/BE838833A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
BE164543A 1975-02-24 1976-02-23 Composes 3-acyloxymethyl-cephemes, leur preparation et leur utilisation BE838833A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2315875A JPS5837316B2 (ja) 1975-02-24 1975-02-24 セフアロスポリンカゴウブツノ セイゾウホウ
JP3375975A JPS5951553B2 (ja) 1975-03-20 1975-03-20 セフアロスポリン化合物の製造法
JP3471475A JPS5951554B2 (ja) 1975-03-21 1975-03-21 セフアロスポリン化合物の製造法
JP127476A JPS5283869A (en) 1976-01-01 1976-01-01 Cephalosporin compounds

Publications (1)

Publication Number Publication Date
BE838833A true BE838833A (fr) 1976-08-23

Family

ID=27453366

Family Applications (1)

Application Number Title Priority Date Filing Date
BE164543A BE838833A (fr) 1975-02-24 1976-02-23 Composes 3-acyloxymethyl-cephemes, leur preparation et leur utilisation

Country Status (18)

Country Link
US (1) US4245088A (sv)
AT (1) AT346486B (sv)
AU (1) AU496914B2 (sv)
BE (1) BE838833A (sv)
CA (1) CA1092095A (sv)
CH (1) CH625245A5 (sv)
DE (1) DE2607064C2 (sv)
DK (3) DK159154C (sv)
ES (2) ES445348A1 (sv)
FR (1) FR2301528A1 (sv)
GB (1) GB1544103A (sv)
HK (1) HK2482A (sv)
HU (2) HU179598B (sv)
MX (1) MX3635E (sv)
NL (1) NL187166C (sv)
NO (1) NO760590L (sv)
PH (1) PH16245A (sv)
SE (2) SE435182B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323676A (en) * 1975-02-24 1982-04-06 Takeda Chemical Industries, Ltd. Process for preparing cephalosporins
BE878433A (fr) * 1978-08-31 1980-02-25 Fujisawa Pharmaceutical Co Procede de preparation de derives d'acide 3-cephem-4-carboxylique 3,7-disubstitue, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
GR70261B (sv) * 1977-12-12 1982-09-02 Takeda Chemical Industries Ltd
ZA825095B (en) * 1981-07-17 1983-05-25 Glaxo Group Ltd Cephalosporin compounds
US4584371A (en) * 1984-03-01 1986-04-22 The Upjohn Company Catalytic process for preparing 3-ester-methyl cephalosporins from desacetyl-7-aminocephalosporanic acid
JP2867438B2 (ja) * 1988-08-10 1999-03-08 武田薬品工業株式会社 セファロスポリン化合物の製造法
US5552542A (en) * 1995-05-10 1996-09-03 Bristol-Myers Squibb Company Preparation and use of 7-[(2-carboalkoxy-1-methylethenyl)amino]-3-hydroxymethyl-3-cephem-4-carboxylic acids
US8198434B2 (en) * 2008-05-07 2012-06-12 Idexx Laboratories, Inc. Process for preparing cefsulodin sodium
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
EP3426663B1 (en) * 2016-03-07 2020-01-29 Dhanuka Laboratories Ltd. A process for alkylating the hydroxymethyl group at position -3 of cephalosporins
NL2022854B1 (en) * 2019-04-03 2020-10-08 Univ Leiden Prodrug inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241657A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds
US4007178A (en) * 1972-04-10 1977-02-08 Smithkline Corporation O-acyl-7-acylaminocephalosporadesic acids

Also Published As

Publication number Publication date
DK63990D0 (da) 1990-03-12
US4245088A (en) 1981-01-13
DK160313B (da) 1991-02-25
DK44076A (da) 1976-08-25
DK76190D0 (da) 1990-03-23
NO760590L (sv) 1976-08-25
AU496914B2 (en) 1978-11-09
ES459261A1 (es) 1978-03-16
ATA126476A (de) 1978-03-15
AU1134976A (en) 1977-09-01
DE2607064C2 (de) 1984-12-13
ES445348A1 (es) 1977-10-16
SE435183B (sv) 1984-09-10
NL187166C (nl) 1991-06-17
DK159154C (da) 1991-02-11
DK159154B (da) 1990-09-10
HU179598B (en) 1982-11-29
AT346486B (de) 1978-11-10
MX3635E (es) 1981-04-13
HU179070B (en) 1982-08-28
DK160313C (da) 1991-07-29
FR2301528B1 (sv) 1979-04-20
SE7907455L (sv) 1979-09-07
PH16245A (en) 1983-08-16
GB1544103A (en) 1979-04-11
DK63990A (da) 1990-03-12
DK161201C (da) 1991-11-25
SE7907454L (sv) 1979-09-07
SE435182B (sv) 1984-09-10
NL7601902A (nl) 1976-08-26
DE2607064A1 (de) 1976-09-02
HK2482A (en) 1982-02-14
FR2301528A1 (fr) 1976-09-17
DK76190A (da) 1990-03-23
CH625245A5 (sv) 1981-09-15
CA1092095A (en) 1980-12-23
DK161201B (da) 1991-06-10

Similar Documents

Publication Publication Date Title
BE885255A (fr) Composes de 10-deazaminopterine, leur preparation et leur utilisation
BE861224A (fr) Esters steroidiques, leur preparation et leur utilisation
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE839255A (fr) Piperazinylimino rifamycines, leur preparation et leur utilisation
BE839038A (fr) Composes d'imidazolium quaternaires, leur preparation et leur utilisation
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
FR2335568A1 (fr) Composes disazoiques, leur preparation et leur utilisation comme pigments
BE838833A (fr) Composes 3-acyloxymethyl-cephemes, leur preparation et leur utilisation
BE839256A (fr) Piperazinylimino rifamycines, leur preparation et leur utilisation
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE861694A (fr) 3-carboxy-4-oxo-1,4-dihydro-1,8-naphtyridines et leur preparation
BE825039A (fr) Leuco-colorants d'indolyl-methylene, leur preparation et leur utilisation
BE868953A (fr) Peptides, leur preparation et leur utilisation
BE835835A (fr) Composes heterocycliques, leur preparation et leur utilisation
BE861351A (fr) Composes alcanoylanilides et leur preparation
BE838233A (fr) Phenyl- et penzylphosphonate esters, leur preparation et leur utilisation
BE848766A (fr) Spiro (cyclopropane-1,2'-indolin)-3'-ones, leur preparation et leur utilisation
BE846802A (fr) Composes de 1,3-benzodithiole-2-one et de 1,3-benzodithiole-2-thione, et leur preparation
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE855591A (fr) Neoviridogriseines, leur preparation et leur utilisation
BE879729A (fr) Composes azotes ortho-condenses tricycliques, leur preparation et leur utilisation
BE842275A (fr) Prostaglandines, leur preparation et leur utilisation
BE838802A (fr) Derives de 3-amino-4-carbamyl-pyrrole, leur preparation et leur utilisation
BE839035A (fr) Derives de triazolobenzocycloalkylthiadiazine, leur preparation et leur utilisation
BE836849A (fr) Dialkylphosphonopropionamides, leur preparation et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: TAKEDA CHEMICAL INDUSTRIES LTD

Effective date: 19920228